HPV Prophylactic Vaccine after Surgical Treatment of Cervical Lesions

IPVS educational webinar: HPV Prophylactic Vaccine after Surgical Treatment of Cervical Lesions

Wednesday, 10 July 2024
16:00 CEST (Geneva) / 10:00 EDT (New York)

Topic:

Participate in this free webinar where our expert panel will explore critical topics including the efficacy of vaccination against original vs. new HPV types post-surgery, diseases with solid evidence of HPV vaccination for preventing recurrence, and insights from the NOVEL trial on optimal timing for protection. By attending, you’ll gain insights to define the role of prophylactic vaccination in preventing lesion recurrence.

WEBINAR AIMS

1. Define the role of prophylactic vaccination use after treatment for recurrence of lesions or lesions at other sites.
2. Quantify the reduction of recurrent or new HPV types after receiving HPV vaccination after surgery at all sites.
3. Recognize the benefits and risks associated with vaccination pre/post-surgery.
4. Are there proofs of successful programs? How can we make this feasible in countries with limited resources?

LECTURES & FACULTY

• Investigate the use of vaccination against original vs. new HPV types after surgical treatment – Marta Del Pino, MD, PhD
• For what diseases we have good proofs of HPV vaccination to prevent recur – Elmar A. Joura, MD
• Results from the NOVEL trial: is timing important for best protection? – Maria Kyrgiou, MSc, PhD MRCOG
• MODERATOR: Caroline Walker, PhD (c)

This webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s).

This webinar will be recorded. If you have missed the previous IPVS webinars, you can watch the videos on demand on the IPVS members’ website.